Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Jenna M SopfeAshley EndresKristen R MillerKari HayesAndrew T TroutXiayuan LiangRobert LorsbachMaureen M O'BrienCarrye R CostPublished in: Pediatric blood & cancer (2019)
Pediatric patients with CD most commonly have unicentric, hyaline vascular variant disease. Pediatric patients with both UCD and MCD commonly have systemic inflammation and, despite risk of progression/relapse in MCD patients, ultimately have excellent survival.